IEG Vu is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Arcadia prices US IPO

The US plant biotechnology company, Arcadia BioSciences (Davis, California), has priced its initial public offering (IPO) of 8.2 million shares of common stock at $8 each. The shares began trading on the Nasdaq global market on May 15th under the symbol, RKDA, Arcadia says. The offering is due to close on May 20th, subject to customary closing conditions. Arcadia has granted the underwriters a 30-day option to purchase up to an additional 1,230,000 shares of common stock. The company initially sought to raise over $90 million from its IPO by offering 7.15 million shares at an estimated price of $13-15/share, with a 30-day option to the underwriters to purchase a further 1,072,500 shares.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts